AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
πΏπΌ
AFOXOLANER; MILBEMYCIN OXIME in Zimbabwe
1 product registered with MCAZ β 1 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| NEXGARD SPECTRA TABLET; ORAL | 2025/80.16.00/9857 | Boehringer Ingelheim Animal Health South Africa (Pty) Ltd | active | 31 Dec 2027 |
AFOXOLANER; MILBEMYCIN OXIME β MCAZ Registration Details
MCAZ (Zimbabwe) has 1 registered product containing AFOXOLANER; MILBEMYCIN OXIME, of which 1 is currently active. Data is sourced directly from the official MCAZ drug register and refreshed daily.
Track AFOXOLANER; MILBEMYCIN OXIME registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.